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PCardiac Imaging
ate Gadolinium-Enhanced Magnetic Resonance
maging in Acute and Chronic Myocardial Infarction
mproved Prediction of Regional Myocardial Contraction in the
hronic State by Measuring Thickness of Nonenhanced Myocardium
asutaka Ichikawa, MD,* Hajime Sakuma, MD,† Naohisa Suzawa, MD,* Kakuya Kitagawa, MD,†
atsutoshi Makino, MD,‡ Tadanori Hirano, MD,* Kan Takeda, MD†
ie, Japan
OBJECTIVES We sought to determine serial changes of enhanced and nonenhanced tissue on late
gadolinium-enhanced cardiac magnetic resonance (CMR) imaging in patients with a
myocardial infarction (MI) and to assess whether thickness of nonenhanced myocardium can
improve the detection of preserved contractile function in the chronic state.
BACKGROUND Previous studies demonstrated that enhancement on late gadolinium-enhanced CMR images
indicates myocardial necrosis, and nonenhancement shows the presence of viable myocar-
dium.
METHODS The CMR studies were performed within one week (scan 1) and more than five months (scan
2) after the onset of MI in 18 patients. The area and mean thickness of enhanced tissue and
nonenhanced myocardium were measured by using a 30-segment model. Systolic wall
thickening on cine CMR at scan 2 was assessed for evaluating regional contractile function.
RESULTS The amount of enhanced tissue significantly decreased from scan 1 to 2 (22.1  14.0 ml vs.
15.0  9.3 ml, p  0.001). The averaged thickness of nonenhanced myocardium in the
infarct segments significantly increased from scan 1 to 2 (5.2  3.0 mm vs. 6.6  3.2 mm,
p  0.001). Receiver operating characteristic analysis demonstrated that the measurement of
thickness of nonenhanced myocardium, compared with measurement of percent transmural
enhancement, had better diagnostic accuracy for predicting improved systolic wall thickening
form scan 1 to 2 in dysfunctional segments (Az 0.650 vs. 0.594, p  0.05).
CONCLUSIONS The amounts of enhanced tissue and nonenhanced myocardium significantly altered from the
acute to chronic state in MI patients. The diagnostic performance of CMR imaging for
detection of preserved contractile function can be significantly improved by measuring
thickness of nonenhanced myocardium in MI patients. (J Am Coll Cardiol 2005;45:901–9)
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.11.058© 2005 by the American College of Cardiology Foundation
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in patients with an acute myocardial infarction (MI),
yocardial salvage is the hallmark of successful coronary
ntervention and results in long-term reestablishment of
yocardial contractile function and improved prognosis
1–4). Ventricular wall motion at rest cannot be used to
uantify salvage early after infarction, as both necrotic and
iable myocardium may demonstrate impaired regional
yocardial contraction (5–7). Consequently, the distinction
etween reversible and irreversible dysfunction early after
nfarction is an important clinical issue. In patients with
hronic ischemic heart disease who exhibit impaired myo-
ardial contraction, the identification of viable and nonvia-
le myocardium is important in predicting whether patients
ill have increased left ventricular (LV) ejection fractions
nd improved survival after revascularization (8–13).
Inversion-recovery cardiac magnetic resonance (CMR)
maging after administration of extracellular contrast agents
From the *Department of Radiology, Matsusaka Central Hospital, Mie; †Depart-
ent of Radiology, Mie University Hospital, Mie; and ‡Department of Internal
edicine, Matsusaka Central Hospital, Mie, Japan.n
Manuscript received April 18, 2004; revised manuscript received November 19,
004, accepted November 29, 2004.as a high spatial resolution and can identify infarcted
yocardium as an area of persistent enhancement (14).
revious studies demonstrated that the transmural extent of
nhancement (percent transmural enhancement) revealed by
ate gadolinium-enhanced CMR imaging is correlated with
lack of improvement of regional contractile function in
atients with acute MI (15–17). In the setting of chronic
I, percent transmural enhancement has been shown to be
redictive of recovery of regional contraction after revascu-
arization (18,19).
A previous study using animal models (20) demonstrated
hat the amount of enhanced necrotic tissue at three days
fter the onset of MI was substantially higher than that at
ight weeks after the onset of MI. Consequently, the
ptimal threshold of percent transmural enhancement for
redicting preserved regional contractile function may be
ifferent between acute and chronic MI. On late
adolinium-enhanced CMR images, noninfarcted myocar-
ium with preserved intracellular space is shown as nonen-
anced myocardium (20). Thus, regional myocardial viabil-
ty might be assessed by measuring the amount of
onenhanced noninfarcted tissue rather than the transmural
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Enhanced and Nonenhanced Tissue in an MI Patient March 15, 2005:901–9xtent of enhanced necrotic tissue. However, there have
een no reports eliciting the relationship between the
mount of nonenhanced myocardium on late gadolinium-
nhanced CMR images in the ischemically injured region
nd preserved regional myocardial contraction in the
hronic state.
In the current study, we evaluated the amounts of
nhanced necrotic tissue and nonenhanced noninfarct tissue
n the acute and chronic states in patients with MI. In
ddition, we compared the diagnostic value of measuring
he thickness of nonenhanced myocardium and that of
easuring percent transmural enhancement in predicting
reserved regional myocardial contraction in the chronic
tate.
ETHODS
atients. This study protocol was approved by the institu-
ional review board, and all patients gave written, informed
onsent. Twenty-five patients (17 men and 8 women; mean
ge 63.2  11.1 years) admitted to the coronary care units
t our hospital with the diagnosis of acute MI, as defined by
ypical chest pain, characteristic abnormal findings on the
lectrocardiogram (ECG), and an increased cardiac creatine
able 1. Patient Characteristics
Pt. #
Age
(yrs) Gender
No. of
Risk Factors IRA
1 54 M 2 LAD
2 56 M 3 LAD
3 77 M 0 LAD
4 74 M 2 LCx
5 60 M 3 LCx
6 61 F 2 LAD
7 70 F 3 RCA
8 47 M 3 LAD
9 65 F 1 RCA
10 59 M 2 LAD
11 60 F 2 RCA
12 46 M 2 LAD
13 57 M 3 RCA
14 57 F 2 LAD
15 64 F 3 RCA
16 54 M 4 RCA
17 87 M 2 LAD
18 76 M 0 RCA
Mean  SD 62  11 2.2  1.0 NA
K  creatine kinase; IRA  infarct-related artery; LAD  left anterior descendin
Abbreviations and Acronyms
CMR  cardiac magnetic resonance
ECG  electrocardiogram or electrocardiographic
LV  left ventricle/ventricular
MI  myocardial infarction
ROC  receiver operating characteristics
TIMI  Thrombolysis In Myocardial InfarctionVEF  left ventricular ejection fraction; MRI  magnetic resonance imaging; NA  not a
IMI  Thrombolysis In Myocardial Infarction.inase-MB fraction enzyme level (9 g/l) were prospec-
ively enrolled. Patients were included if they had no history
f MI, showed single-vessel disease, underwent successful
ercutaneous transluminal coronary angioplasty with 50%
esidual stenosis, were clinically stable, had no contraindi-
ations to CMR imaging, and could be scanned within one
eek.
The study population consisted of the 18 patients who
ad a second MR scan more than five months later (scan 2).
f the seven patients without a second CMR study, three
oved to other hospitals and four refused to undergo a
econd CMR scan. No patient was excluded for technical or
mage quality reasons. No patient had clinical evidence of a
ew MI or restenosis of the coronary artery between the first
nd second scans.
rotocol for MR imaging. The patient was placed supine
n a clinical 1.5-T imager (Magnetom Vision; Siemens,
rlangen, Germany) with body-array coils around the chest.
he CMR images were gated to the ECG and obtained
uring repeated breath-holds. The first CMR imaging was
erformed at a mean of 4.2 1.4 days after the onset of MI
scan 1). The second CMR image (scan 2) was obtained at
mean of 294.3  122 days after the onset of MI and a
ean of 290  121 days after the first CMR imaging.
Late gadolinium-enhanced CMR images were obtained
ith a segmented inversion-recovery, fast, low-angle shot
equence on contiguous short-axis imaging planes 15 min
fter intravenous administration of 0.15 mmol/kg gado-
entetate dimeglumine (Magnevist, Schering AG, Berlin,
ermany) (21). The CMR imaging parameters included a
epetition time of 6.0 ms, an echo time of 3.4 ms, an
nversion time of 200 to 250 ms, a trigger delay time for
ST-Segment
Elevation
Time to
Reperfusion
(h)
TIMI Flow
Grade After
PCI
Peak CK
(U/l)
Y 4 3 3,874
Y 2 3 3,770
Y 3 3 4,260
N 2 3 859
N 4 3 213
Y 4 3 5,989
N 5 3 3,083
Y 4 2 6,060
Y 2 3 961
Y 24 3 2,048
Y 3 3 1,561
Y 2 3 7,700
Y 3 3 5,283
Y 6 3 2,363
Y 4 3 1,660
N 3 3 566
Y 3 3 4,275
Y 2 2 1,531
14/18 3.0  1.0 2.9  0.3 3,114  2,165
ry; LCx  left circumflex artery; LVEDV  left ventricular end-diastolic volume;g arte
pplicable; PCI  percutaneous coronary intervention; RCA  right coronary artery;
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March 15, 2005:901–9 Enhanced and Nonenhanced Tissue in an MI Patientnversion recovery pulse of 200 ms, a section thickness of 10
m, a field of view of 240  320 mm, and image matrix of
92  256.
Cine CMR images encompassing the entire LV were
cquired on contiguous short-axis imaging planes with a
egmented, fast, low-angle shot cine sequence. The follow-
ng imaging parameters were used: a repetition time of 50
s for each cine frame, an echo time of 4.8 ms, a section
hickness of 10 mm, a field of view of 240  320 mm, and
n image matrix of 192  256. The scan parameters were
ame for scan 1 and scan 2.
mage analysis. Cine and late gadolinium-enhanced CMR
mages were assessed on separate days. For the assessments
f global LV volume, ejection fraction, and mass and the
otal volume of enhanced and nonenhanced tissue, all
hort-axis planes encompassing the entire LV on cine and
ate gadolinium-enhanced CMR imaging were analyzed.
or the segment-to-segment comparison between cine and
ate gadolinium-enhanced CMR images, we used a 30-
egment model in which the LV was divided into six
ircumferential segments on five basal and mid-ventricular
hort-axis views. Apical segments were omitted from the
egment-to-segment analysis because precise evaluation of
ystolic wall thickening, percent transmural enhancement,
nd thickness of nonenhanced tissue was difficult to deter-
ine due to partial-volume averaging.
Late gadolinium-enhanced images from scans 1 and 2
ere randomized and evaluated by two observers who were
linded to patient identity. Two observers manually traced
he borders of the epicardium, endocardium, and enhanced
issue on short-axis, contrast-enhanced CMR images, by
onsensus with the use of commercial software (MASSPlus,
able 1 Continued
Peak
CK-MB
(g/l)
Infarct Size on
MRI Scan 1
(cm3)
Infarct Size on
MRI Scan 2
(cm3)
LVE
S
517 47.5 35.2 1
292 28.8 24.6 1
309 27.7 20.1 1
84 7.6 6.6 1
24 7.7 4.6 1
646 35.0 22.6 1
149 12.1 7.3
585 35.6 20.5 1
117 7.5 6.5
180 14.5 11.0 1
156 9.9 5.8 1
680 44.3 18.8 2
402 11.4 8.9 1
594 21.5 12.7 1
219 12.0 11.1 1
57 5.2 3.4 1
548 34.5 26.7
288 36.0 24.4
304  207 22.1  14.0 15.0  9.3 119.1EDIS Medical Imaging Systems, Leiden, the Nether-
ands). Papillary muscles were excluded from the myocar-
ium. After determining the total volume of enhanced
issue, the percentage of enhanced tissue for total LV
yocardium was calculated as follows: (volume of enhanced
issue  100/total volume of LV myocardium) (%). The
otal volume of nonenhanced myocardium was calculated as
ollows: (total volume of LV wall  volume of enhanced
issue) (ml). For segmental analysis, the thickness of en-
anced tissue and that of nonenhanced tissue were mea-
ured along 100 chords that were equally distributed along
he circumference of the LV. The mean thickness of
onenhanced myocardium and the mean percent transmural
nhancement in each segment were determined by averag-
ng the measurements in each segment.
Cine images from scan 2 were randomized and analyzed
y two observers who were blinded to patient identity and
esults on late enhancement. Two observers manually traced
he borders of the epicardium and endocardium on short-
xis cine CMR images by consensus with the use of
ASSPlus. Papillary muscles were excluded from the
yocardium. Left ventricular end-diastolic volume, end-
ystolic volume, ejection fraction, and mass were measured.
jection fraction was calculated as follows: ([end-diastolic
olume  end-systolic volume]  100/end-diastolic vol-
me) (%). For segmental analysis, the systolic wall thicken-
ng on scan 2 was determined as followed: ([end-systolic
all thickness  end-diastolic wall thickness]  100/end-
iastolic wall thickness) (%).
The threshold of regional percent wall thickening for
eparating the segments with preserved and impaired con-
ractile function was determined as follows. First, we se-
on LVEF on
Scan 2
(%)
Onset to MRI
on Scan 1
(days)
Onset to MRI
on Scan 2
(days)
54.3 3 191
48.3 5 188
50.5 4 245
65.0 6 545
64.5 3 243
37.3 2 450
61.2 6 562
45.4 7 219
58.8 3 190
62.6 4 275
60.1 3 236
36.4 5 395
46.8 5 226
27.3 3 156
66.7 4 220
65.1 5 368
51.4 4 320
64.5 3 268
8.8 53.7  11.6 4.2  1.3 294  122DV
can 2
(ml)
17.2
44.1
12.5
03.1
03.9
21.3
86.6
15.3
94.7
24.6
04.2
09.5
11.5
44.5
25.6
42.2
88.7
95.0
 2
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Enhanced and Nonenhanced Tissue in an MI Patient March 15, 2005:901–9ected 132 normal segments without any enhancement and
1 segments with transmural enhancement by assessing late
adolinium-enhanced CMR images. Then, receiver operat-
ng characteristic (ROC) analysis was performed to obtain
n optimal threshold of regional percent wall thickening for
istinguishing the segments with preserved and impaired
ontraction function. The optimal cut-off value of 22% was
etermined by the intersection of the ROC curve with the
econd bisectrix at which the sensitivity and specificity were
dentical (22). The sensitivity and specificity were 90.7% at
his threshold value.
tatistical analysis. All values were expressed as the mean
alue  SD. The statistical significance of differences
etween the areas under ROC curves was evaluated with a
nivariate z score test. A value of p  0.05 was considered
o be statistically significant.
igure 1. Contrast-enhanced magnetic resonance images in the acute state
A) and chronic state (B), and cine images in the chronic state (C, diastole;
, systole) in Patient #11 after an inferior myocardial infarction. The
Table 2. Left Ventricular Volumes, Mass, and
Global left ventricular volumes
End-diastolic volume (ml)
End-systolic volume (ml)
Ejection fraction (%)
Left ventricular mass (ml)
Contrast-enhanced magnetic resonance images
Volume of nonenhanced myocardium (ml)
Volume of enhanced tissue (ml)
Percentage of enhanced tissue (%)
Data are presented as the mean value  SD.nferior wall demonstrated normal wall thickening on the cine images
cquired in the chronic state.
c
iESULTS
able 1 summarizes the clinical data of the patient popu-
ation. The mean time between the onset of MI and
eperfusion was 3.0 1.0 h, and the mean Thrombolysis In
yocardial Infarction (TIMI) flow grade after reperfusion
as 2.9  0.3 in the patients who underwent both CMR
cans 1 and 2. At coronary angiography, the infarct-related
rtery was the left anterior descending coronary artery
erritory in nine patients, the right coronary arterial territory
n seven patients, and the left circumflex coronary arterial
erritory in two patients. Late gadolinium-enhanced CMR
mages demonstrated enhancement in all subjects. Myocar-
ial enhancement was observed in 216 (40%) of the 540
egments (18 patients  30 segments  540). The LV
nd-diastolic volume, LV end-systolic volume, LV ejection
igure 2. Contrast-enhanced magnetic resonance images in the acute state
A) and chronic state (B), and cine images in the chronic state (C, diastole;
, systole) in Patient #12 after an anteroseptal myocardial infarction. The
mes of Nonenhanced and Enhanced Tissue
cute State
(Scan 1)
Chronic State
(Scan 2) p Value
5.4  29.0 119.1  28.8 NS
6.1  23.1 56.8  26.5 NS
2.6  11.0 53.7  11.6 NS
1.2  32.7 106.3  30.7 NS
9.0  25.6 91.5  26.3 NS
2.1  14.0 15.0  9.3 0.001
9.4  9.1 13.6  6.6 0.001Volu
A
11
5
5
11
8
2
1ontractility of the anteroseptal wall was not improved in the chronic state
n this patient.
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March 15, 2005:901–9 Enhanced and Nonenhanced Tissue in an MI Patientraction, and total LV mass measured by cine CMR
maging at scans 1 and 2 are summarized on Table 2. No
ignificant difference was observed between scan 1 and 2
or the LV volume, LV ejection fraction, and total LV
ass.
otal volumes of late-enhanced tissue and nonenhanced
yocardium in the acute and chronic states. Table 2
ummarizes total volumes of enhanced tissue and nonen-
anced myocardium at scans 1 and 2. The total volume of
nhanced tissue significantly decreased from scan 1 to 2
22.1  14.0 ml vs. 15.0  9.3 ml, p  0.001) (Figs. 1 and
). The percentage of enhanced tissue compared with total
igure 3. The relationship between the thickness of nonenhanced myocar
tate, as well as the relationship between the percent transmural enhanceme
n the 216 segments showing late enhancement.V mass significantly decreased from scan 1 to 2 as well (19.4  9.1% vs. 13.6  6.6%, p  0.001). No significant
ifference was observed between scan 1 and 2 for the total
olume of nonenhanced myocardium and LV mass.
ate-enhanced tissue and nonenhanced myocardium in
he infarct segments in the acute and chronic states. The
ean thickness of enhanced tissue at scan 2 (5.4 3.3 mm)
as significantly less than that at scan 1 (7.7  3.3 mm, p
0.001). The percent transmural enhancement at scan 2
44.8  22.2%) was also significantly less than that at scan
(59.7  21.2%, p  0.001). In contrast, the mean
hickness of nonenhanced myocardium at scan 2 (6.6  3.2
m) significantly increased compared with that at scan 1
on scan 1 (A) and scan 2 (B) and systolic wall thickening in the chronic
scan 1 (C) and scan 2 (D) and systolic wall thickening in the chronic statedium
nt on5.2  3.0 mm, p  0.001).
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Enhanced and Nonenhanced Tissue in an MI Patient March 15, 2005:901–9elationship between the measurements on late-
nhanced CMR images and systolic wall thickening in
he chronic state. Figure 3 shows the relationship between
he thickness of nonenhanced myocardium at scans 1 and 2
nd systolic wall thickening in the chronic state, as well as
he relationship between the percent transmural enhance-
ent at scans 1 and 2 and systolic wall thickening in the
hronic state in the 216 segments showing late enhance-
ent. A significant positive correlation was observed be-
ween the thickness of nonenhanced myocardium measured
n the acute and chronic states and systolic wall thickening
n the chronic state (scan 1: r  0.51, p  0.001; scan 2:
 0.56, p  0.001). The percent transmural enhancement
easured in the acute and chronic states demonstrated a
ignificant negative correlation with systolic wall thickening
n the chronic state (scan 1: r  0.51, p  0.001; scan 2:
 0.48, p  0.001).
The ROC curves of late gadolinium-enhanced CMR
maging for detecting preserved contractile function on scan
are shown in Figure 4. The area under the ROC curve
igure 4. The receiver operating characteristic curves of contrast-enhan
ransmural enhancement (dotted line) and with measurements of thickne
unction in the chronic state. The area under the receiver operating charac
as significantly higher than that with the measurements of percent trans
able 3. Test Performance of Contrast-Enhanced Magnetic Reso
he Chronic Phase
Acute State
Percent Transmural
Enhancement
Thickness
Myo
Optimal Thresholds 69.7% 3
ensitivity (%) 78.2 (111/142) 79.6
pecificity (%) 78.4 (58/74) 79.7
ositive predictive value (%) 87.4 (111/127) 88.3
egative predictive value (%) 65.2 (58/89) 67.0
ccuracy (%) 78.2 (169/216) 79.6 (172/ith the measurements of thickness of nonenhanced myo-
ardium was 0.872 for scan 1 and 0.928 for scan 2, being
ignificantly higher than those obtained by the measure-
ents of percent transmural enhancement (scan 1: 0.846, p
0.05; scan 2: 0.819, p  0.001).
The optimal threshold of the thickness of nonenhanced
yocardium for predicting preserved systolic wall thicken-
ng (22%) in the chronic state, as determined by ROC
nalysis, was 3.9 mm for scan 1 and 5.1 mm for scan 2. The
ptimal thresholds of percent transmural enhancement for
etecting preserved systolic wall thickening in the chronic
tate was 69.7% for scan 1 and 52.4% for scan 2 for the
hronic phase. The sensitivity, specificity, and diagnostic
ccuracy of late contrast-enhanced CMR imaging for pre-
icting preserved systolic wall thickening with the measure-
ents of thickness of nonenhanced myocardium were
9.6%, 79.7%, and 79.6% in the acute phase and 88.7%,
7.8%, and 88.4% in the chronic phase, respectively (Table
). The sensitivity, specificity, and diagnostic accuracy of
ate-enhanced CMR imaging for predicting preserved sys-
ardiac magnetic resonance imaging with the measurements of percent
nonenhanced myocardium (solid line) for detecting preserved contractile
c curve with the measurements of thickness of nonenhanced myocardium
l enhancement for both scans 1 and 2.
e Imaging in the Diagnosis of Preserved Wall Thickening in
Chronic State
nenhanced
ium
Percent Transmural
Enhancement
Thickness of Nonenhanced
Myocardium
52.4% 5.1 mm
142) 76.1 (108/142) 88.7 (126/142)
4) 75.7 (56/74) 87.8 (65/74)
128) 85.7 (108/126) 93.3 (126/135)
8) 62.2 (56/90) 80.2 (65/81)ced c
ss ofnanc
of No
card
.9 mm
(113/
(59/7
(113/
(59/8216) 75.9 (164/216) 88.4 (191/216)
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March 15, 2005:901–9 Enhanced and Nonenhanced Tissue in an MI Patientolic wall thickening with the measurements of percent
ransmural enhancement were 78.2%, 78.4%, and 78.2% in
he acute phase and 76.1%, 75.7%, and 75.9% in the chronic
hase, respectively.
rediction of the improvement of regional wall thicken-
ng from the acute to chronic phase in dysfunctional
egments by measuring thickness of nonenhanced myo-
ardium. Figure 5 shows ROC curves of late gadolinium-
nhanced CMR imaging for predicting improved systolic
all thickening from scan 1 to 2 in the 110 segments
howing impaired contractile function on scan 1 (22%
all thickening). The area under the ROC curve by mea-
uring thickness of nonenhanced myocardium was 0.650,
eing significantly higher than that by measuring percent
ransmural enhancement (0.594, p  0.05).
ISCUSSION
ate gadolinium-enhanced CMR imaging of the myocar-
ium has become increasingly important as a noninvasive
ethod for demonstrating MI. In the current study, we
ound that the total volume and transmural extent of
nhanced necrotic tissue significantly decreased, and the
ean thickness of nonenhanced myocardium in infarct
egments significantly increased from the acute to chronic
tate. The ROC analysis (Fig. 4) indicated that regional
ystolic wall thickening in the infarcted segments in the chronic
tate has a more close association with thickness of nonen-
igure 5. The receiver operating characteristic curves of late gadolinium-
nhanced cardiac magnetic resonance imaging with the measurements of
ercent transmural enhancement (dotted line) and with measurements of
hickness of nonenhanced myocardium (solid line) for detecting improved
ontractile function from scan 1 to 2 in the 110 segments showing impaired
ontractile function on scan 1 (22% systolic wall thickening). The area
nder the receiver operating characteristic curve with the measurements of
hickness of nonenhanced myocardium was significantly higher than that
ith measurements of percent transmural enhancement.anced myocardium than with percent transmural enhance- (ent. These results indicate the value of measuring thickness
f nonenhanced myocardium in the infarct segments in pre-
icting regional myocardial contractile function.
In this study, we evaluated the changes in enhanced tissue
nd nonenhanced myocardium from the acute and chronic
tate in patients with MI and observed a significant reduc-
ion in the total volume of enhanced tissue by 32% (22.1
14.0 ml vs. 15.0  9.3 ml). The mean thickness of
nhanced tissue in the infarct segments decreased similarly
y 30% (7.7  3.3 mm vs. 5.4  3.3 mm), and the mean
hickness of nonenhanced myocardium in the infarct seg-
ents increased by 27% (5.2  3.0 mm vs. 6.6  3.2 mm,
 0.001). These findings in clinical patients agree with
he results of previous studies using animal models (20,23).
im et al. (20) measured the total volume of late-enhanced
issue in the dogs at both three days and eight weeks after
he onset of MI in a single coronary artery territory. They
eported that the total volume of the enhanced necrotic
issue decreased by a factor of 3.4  1.4, and the total
olume of nonenhanced noninfarcted myocardium in-
reased by 1.2 0.2-fold at eight weeks in comparison with
hree days after the onset of MI. A time-related reduction of
nfarcted tissue was observed in humans as well after the
nset of acute MI (24). The reduction of late-enhanced area
rom the acute to chronic state can be explained that the
patial extent of collageneous scar in the chronic sate is
maller than the spatial extent of myocyte necrosis in the
cute state. Although the exact mechanism for the increase
n nonenhanced myocardium has not been determined, it
an be explained by compensatory hypertrophy. Compen-
atory hypertrophy may occur not only in noninfarcted
yocardium in the infarct-related segments but also in the
djacent segments without infarction.
The assessment of percent transmural enhancement has
een proven to be useful in evaluating patients with a recent
I, as well as those with chronic MI. In this study, we
ound that the optimal threshold for predicting the seg-
ents with preserved contractile function is different be-
ween acute and chronic MI. This observation has an
mportant implication when assessing infarct segments with
n intermediate extent of enhancement. Choi et al. (15)
eported that in patients within one week after the onset of
I, 67% of myocardial segments with a 1% to 25%
ransmural extent of enhancement exhibited improved con-
ractile function in the chronic state, but only 5% of
egments with 76% to 100% transmural extent of enhance-
ent showed improvement. Similarly, in patients with
hronic MI, Kim et al. (18) found that 60% of the
yocardial segments with a 1% to 25% transmural extent of
nhancement improved after revascularization, and the like-
ihood of functional recovery was very limited in the
egments with a 76% to 100% transmural extent of en-
ancement. In the segments showing a 50% to 75% trans-
ural extent of enhancement, no functional recovery was
bserved in 90% of the segments. In contrast, Choi et al.
15) observed a higher likelihood of the functional recovery
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xtent of enhancement in patients with acute MI. In our
urrent study, the optimal threshold of percent transmural
nhancement in predicting the segments with preserved con-
ractile function was 69.7% for acute MI and 52.4% for chronic
I, which corresponds clearly with previous studies.
There has been no previous report investigating the value
f measuring the thickness of nonenhanced myocardium in
he infarcted segment on late gadolinium-enhanced CMR
mages in patients with MI. Accordingly, we determined
he diagnostic accuracy of measuring thickness of nonen-
anced myocardium by using ROC analysis (Fig. 4) and
ound that thickness of nonenhanced myocardium is a
etter predictor of preserved regional myocardial contrac-
ion in the chronic state. In the chronic state, the thickness
f nonenhanced myocardium had a more close relation to
ystolic wall thickening, and thickness of nonenhanced
yocardium of 5.1 mm can predict preserved systolic wall
hickening with excellent sensitivity (88.7%) and specificity
87.8%). For late gadolinium-enhanced CMR images ac-
uired in the acute phase, thickness of nonenhanced myo-
ardium exhibited significantly improved diagnostic perfor-
ance in comparison with percent transmural extent for the
rediction of preserved contractile function in the chronic
hase. Thickness of nonenhanced myocardium of3.9 mm
n the acute phase can predict preserved systolic wall
hickening (22%) in the chronic state with a sensitivity of
9.6% and specificity of 79.7%. However, the difference in
he area under the ROC curves was relatively small for
adolinium-enhanced CMR images obtained in the acute
hase. In order to clarify the value of measuring the
hickness of nonenhanced myocardium in patients with
cute MI, we analyzed the relationship between nonen-
anced wall thickness in the acute state and improvement of
ystolic wall thickening between scans 1 and 2 in the
egments showing impaired wall thickening on scan 1. The
OC curve analysis (Fig. 5) demonstrated that the thick-
ess of nonenhanced myocardium on scan 1 is a significantly
etter predictor of functional improvement during the
ollowing five months, compared with percent transmural
nhancement.
Several potential limitations should be acknowledged. In
he current study, the relationship between the thickness of
onenhanced myocardium and systolic wall thickening was
nvestigated by using a segment-to-segment comparison. In
anaging patients with MI, it is important to determine the
elationship between the amount and distribution of non-
nhanced myocardium on late-enhanced CMR imaging and
mproved global LV function over time. Further study will
e required to determine whether assessment of nonen-
anced myocardium on late-enhanced CMR imaging can
redict improved LV function in the chronic phase. The
iagnostic performance of late gadolinium-enhanced CMR
as significantly improved by measuring the thickness of
onenhanced myocardium instead of percent transmural
xtent of enhancement. However, it should be acknowl-dged that the difference of diagnostic performance was
elatively limited, and sufficient diagnostic accuracy was
btained by assessing percent transmural extent of enhance-
ent. Regional systolic wall thickening was used as a
eference method in determining regional myocardial con-
ractility. Despite the use of standard imaging procedures
nd anatomic landmarks, misregistration may be caused by
nfarction due to scar formation and remodeling. In addi-
ion, the effect of through-plane motion, especially in basal
egments, cannot be eliminated when cine CMR imaging is
mployed. A recent study (25) reported that in patients with
hinned myocardial segments and LV dilation, these regions
ith thinned myocardium (5.5 mm thickness) may dem-
nstrate significantly improvement after revascularization.
he difference of the observations of the Shah et al. (25)
tudy from those of our current study seems to be primarily
elated to the fact that the Shah et al. (25) study focused on
atients demonstrating severely dilated LVs. In our current
tudy, all patients had successful reperfusion, and the
verage TIMI flow grade after coronary intervention was 2.9
0.3. Consequently, global LV function was relatively
reserved in most patients. The diagnostic value of measur-
ng the thickness of nonenhanced myocardium and percent
ransmural enhancement in MI patients should be further
valuated by studying a larger number of MI patients
xhibiting various LV dimensions.
onclusions. The amounts of enhanced tissue and nonen-
anced myocardium significantly altered from the acute to
hronic state in patients with MI. The diagnostic perfor-
ance of late gadolinium-enhanced CMR imaging for
etection of preserved contractile function can be signifi-
antly improved by measuring the thickness of nonenhanced
yocardium in MI patients without severe LV dilation.
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